Cite Filings / IRLA / 0001104659-25-014182
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
SCHEDULE 13G

Statement of Beneficial Ownership

IRulya Therapeutics Inc. · Filed 2025-02-14 · Acc 0001104659-25-014182

Documents 1

  • SCHEDULE 13G Statement of Beneficial Ownership , xslSCHEDULE_13G_X01/primary_doc.xml

Around this filing

  • 2025-08-14 SCHEDULE 13G Statement of Beneficial Ownership
  • 2025-02-18 SCHEDULE 13G/A Statement of Beneficial Ownership
  • 2025-02-14 SCHEDULE 13G Statement of Beneficial Ownership
  • 2025-02-11 4 Options or other derivatives
  • 2025-02-11 4 Options or other derivatives
  • 2025-02-11 4 Options or other derivatives

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)

Stakes reported in this filing

Stake history · largest stake in each 13D and 13G

  1. 2026-11-16 SCHEDULE 13G/A · Squadron Master Fund LP 8.8%
  2. 2026-11-16 SCHEDULE 13G/A · Ikarian Capital, LLC 2.3%
  3. 2026-11-16 SCHEDULE 13G/A · BALYASNY ASSET MANAGEMENT L.P. 9.99%
  4. 2026-11-16 SCHEDULE 13G/A · SilverArc Capital Management, LLC 7.9%
  5. 2026-11-13 SCHEDULE 13G · SilverArc Capital Management, LLC 7.9%
Loading xslSCHEDULE_13G_X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…